Galmed Pharma Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
Galmed Pharma Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases Galmed Pharmaceuticals (NASDAQ:GLMD) Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for...
A Closer Look at VCI Global’s Revenue Growth and Business Model
A Closer Look at VCI Global’s Revenue Growth and Business Model VCI Global (NASDAQ: VCIG) is a multi-disciplinary business and consulting firm, specializing in sectors such as listing solutions, strategic consultancy, fintech, AI, robotics, and cybersecurity. Since...
Organon (NYSE: OGN) to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA Cream, 1%
Organon (NYSE: OGN) to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA Cream, 1% Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Ltd. announced today...
